![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12â15 June 2019 - ()] Poster Presentations - FRI0121â IMPROVEMENT OF MATRIX METALLOPROTEINASE-3 AT 12 WEEKS IS AN INDEPENDENT PREDICTIVE FACTOR FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT 52 WEEKS IN BIO-SWITCH RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT
Takahashi, Nobunori, Kojima, Toshihisa, Asai, Shuji, Ishiguro, NaokiYear:
2019
DOI:
10.1136/annrheumdis-2019-eular.2338
File:
PDF, 210 KB
2019